Korba BE, et al.: Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide. Antimicrob Agents Chemother 52: 4069-4071, 2008.
Korba BE, et al.: Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Antiviral Res 77: 56-63, 2008.
Elazar M, et al.: Nitazoxanide (NTZ) is an inducer eIF2a and PKR phosphorylation (abstr). Hepatology 48: 1151A, 2008.
Rossignol JF, Kabil SM, El-Gohary Y, et al.: Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4. Aliment Pharmacol Ther 28: 574-580, 2008.